Login
Evidence Feed
About
Diagnostics
New
Top genes
FAQ
Contact us
^
Login
Contact us
to learn more about
our Premium Content: News alerts, weekly reports and conference planners
DRUG:
177Lu-LNC1004
i
Other names:
177Lu-LNC1004, 177Lu-EB-FAPI
Contact us
to learn more about our Premium Content:
News alerts, weekly reports and conference planners
Associations
News
Trials
Company:
Dongcheng Pharma
Drug class:
Beta radiation emitter, FAP inhibitor
Related drugs:
‹
lutetium Lu 177 vipivotide tetraxetan (4)
lutetium Lu 177 dotatate (2)
CLR 131 (2)
177Lu-HER3 ARC (0)
177Lu-LNC1003 (0)
TLX591 (0)
AAA603 (0)
CAM-H2 (0)
Cu-67 SAR-Bombesin (0)
EBTATE (0)
ITM-31 (0)
yttrium-90 microspheres (0)
177Lu-edotreotide (0)
yttrium 90 microspheres (0)
177 Lu-FC705 (0)
AAA614 (2)
177Lu-DOTA-EB-FAPI (0)
BI 765179 (0)
MP0310 (0)
MP0317 (0)
NG-641 (0)
RG7827 (0)
SHR-7367 (0)
[177Lu]FAPI-46 (0)
RG7461 (0)
BXCL701 (0)
lutetium Lu 177 vipivotide tetraxetan (4)
lutetium Lu 177 dotatate (2)
CLR 131 (2)
177Lu-HER3 ARC (0)
177Lu-LNC1003 (0)
TLX591 (0)
AAA603 (0)
CAM-H2 (0)
Cu-67 SAR-Bombesin (0)
EBTATE (0)
ITM-31 (0)
yttrium-90 microspheres (0)
177Lu-edotreotide (0)
yttrium 90 microspheres (0)
177 Lu-FC705 (0)
AAA614 (2)
177Lu-DOTA-EB-FAPI (0)
BI 765179 (0)
MP0310 (0)
MP0317 (0)
NG-641 (0)
RG7827 (0)
SHR-7367 (0)
[177Lu]FAPI-46 (0)
RG7461 (0)
BXCL701 (0)
›
Associations
News
Trials
VERI cancer hierarchy
Reset Filters
^
^
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login
Full access to predictive biomarker details and heatmap analytics are available with a VERI Account.
Sign up for FREE
Already have an account?
Login